Tonometer disinfection failure puts patients at risk

Article

Many UK institutions are not compliant with current international guidelines on tonometer disinfection, according to a study published in the August 2008 issue of Eye.

Many UK institutions are not compliant with current international guidelines on tonometer disinfection, according to a study published in the August 2008 issue of Eye.

Roxane J. Hillier, MRCOphtha of Manchester Royal Eye Hospital, UK and colleagues conducted a telephone questionnaire of a senior nurse at every ophthalmology unit with training recognition in the UK (n=155) to compare current tonometer disinfection practice with published guidelines. Of the respondents, 23% (n=35) were excluded immediately as they reported that they used only disposable tonometer heads. The remaining 77% (n=120) used either reusable or a combination of reusable and disposable heads.

A chlorine-based solution was used to disinfect 67% of units (n=80). The concentration of chlorine used ranged from 125 to 30000 ppm, although 63% of units (n=50) used a concentration of <5000 ppm, which is the strength of disinfection recommended in published guidelines. Other disinfectant solutions used included: isopropyl alcohol (n=18), hydrogen peroxide (n=12), chloramine (n=5), chlorhexidine (n=4) and peracetic acid (n=1). One tonometer head per practitioner was provided in 29% of units (n=29); it is likely that these practitioners do not have sufficient time to disinfect these heads between patients. All units questioned replenished disinfectant daily, which is adequate for all solutions except hydrogen peroxide: of the 12 units using this disinfectant, 75% (n=9) did not replenish the solution (as required) twice daily.

The researchers concluded that, although the disinfection practices vary quite widely across the country, most units in the UK do not meet internationally recommended health and safety guidelines on tonometer head disinfection, leaving patients vulnerable to the risk of infection.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.